Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
Phase 1/2a First-In-Human Study of BMS-986207 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.